Hyman, Phelps & McNamara, P.C.
Josephine Torrente’s practice focuses on bringing promising new drug and biological therapies through the FDA approval process. With more than 30 years of experience in the industry, Josephine provides essential regulatory insight and strategic perspective into the pursuit of aggressive objectives.
Josephine advises biotech and pharmaceutical senior executives and development teams on strategic direction at critical moments in drug development, from preclinical and Phase 1 matters to complex Phase 3 study design issues, and advisory committee preparation. Key to her success is the ability to fully understand and address or challenge FDA concerns at the earliest possible time.
Josephine also routinely leads teams of specialized HPM attorneys in conducting FDA-related diligence, providing practical and actionable advice that help clients make determinations on acquisitions and valuations.